• Contact us
    • General Contact
    • Business Development Contact
    • Pharmacovigilance
  • CSR
  • Insud Pharma
  • Español
mAbxience is a fully integrated biopharmaceutical company specialized in research, development and manufacturing of biosimilars for the treatment and/or prevention of several diseases in diverse therapeutic areas.
  •  Company
    • About us
    • CEO Message
    • Leadership Team
    • Business Growth story
    • Manifesto
    • Our locations
  • R&D
    • Biosimilars
    • Portfolio
    • Quality by design
  • Manufacturing
    • Single-Use Technology
    • Facilities
  • CDMO
  • Partnerships
    • B2B (Business to Business)
  • Media
    • News
    • What’s next? Meet us at…
    • Blog mAbxience
  • Join us
  •  Company
    • About us
    • CEO Message
    • Leadership Team
    • Business Growth story
    • Manifesto
    • Our locations
  • R&D
    • Biosimilars
    • Portfolio
    • Quality by design
  • Manufacturing
    • Single-Use Technology
    • Facilities
  • CDMO
  • Partnerships
    • B2B (Business to Business)
  • Media
    • News
    • What’s next? Meet us at…
    • Blog mAbxience
  • Join us
  • Contact us
    • General Contact
    • Business Development Contact
    • Pharmacovigilance
  • CSR
  • Insud Pharma
  • Español

mAbxience | Glossary

Find here all you need!

VIEW ALL
A - Z
Z - A
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

Active ingredient (or active substance)

ANTIBODY

ANTIGEN

ANTIGEN DETERMINANT

ANTIGENITCITY

AVIDITY

B

BACTERIOPHAGE

BACULOVIRUS

BATCH CULTURE

BINDING

BIOACTIVITY

BIOAVAILABILITY

BIOEQUIVALENCE

BIOLOGICAL DRUGS

BIOPHARMACEUTICAL

BIOPROCESSING

BioSim

BIOSIMILAR

BIOSIMILARITY

BIOTECHNOLOGY

C

CBER

CELL BANK

CELL CULTURE

CELL HARVESTING

CELL LINE

cGMP

CHIMERIC TRANSGENE

CHMP

CLINICAL STUDY TRIAL

CLONE

COMPARABILITY

E

EMA

EXTRAPOLATION

F

FDA

FEED

FINGERPRINT-LIKE

FORMULATION

Fucosylation

G

GENE TRANSFER

GENETIC ENGINEERING

GLYCOSYLATION

GMP

H

HAPTEN

HIGH-AFFINITY ANTIBODY

HLA

I

IMMUNOGENICITY

INNOVATIVE REFERENCE DRUG

INTERCHANGEABILITY

M

Mab

MANUFACTURING SCALE PRODUCTION

Marketing authorisation

MCB (MASTER CELL BANK)

MEDIA

MONOCLONAL ANTIBODY (MAB)

O

ORIGINATOR COMPANY

OUTSOURCING ACTIVITIES

P

Patent

PERFORMACE QUALIFICATION

PHARMACODYNAMIC TEST

PHARMACOKINETIC TEST

PHARMACOVIGILANCE

Q

QUALITY

R

Risk management system

S

SIMILARITY

SINGLE-USE TECHNOLOGY

SUBSTITUTION

T

TRACEABILITY

  • Portfolio
  • Blog mAbxience
  • Contact Us
  • Privacy & Terms
  • Cookies Policy
  • Glossary

© 2019 mAbxience. Compañía biotecnológica especializada en biosimilares